New Post Public Reply Private Reply Replies (0) Message Board ← Newer Older → Chrisdc73 Churbz83 #12296 Dec 3, 2014 at 7:37 AM I guess they could sell Lympro, buy another undervalued diagnostic, and spin off the diagnostic division. Way too many scenarios though. Exciting times in next few weeks. Amarantus Bioscience Holdings (AMBS) Stock Research Links AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials Newer Older
